16-72076510-T-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_020995.4(HPR):āc.476T>Cā(p.Ile159Thr) variant causes a missense change. The variant allele was found at a frequency of 0.000817 in 1,614,130 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00055 ( 1 hom., cov: 32)
Exomes š: 0.00084 ( 2 hom. )
Consequence
HPR
NM_020995.4 missense
NM_020995.4 missense
Scores
8
11
Clinical Significance
Conservation
PhyloP100: 3.71
Genes affected
HPR (HGNC:5156): (haptoglobin-related protein) This gene encodes a haptoglobin-related protein that binds hemoglobin as efficiently as haptoglobin. Unlike haptoglobin, plasma concentration of this protein is unaffected in patients with sickle cell anemia and extensive intravascular hemolysis, suggesting a difference in binding between haptoglobin-hemoglobin and haptoglobin-related protein-hemoglobin complexes to CD163, the hemoglobin scavenger receptor. This protein may also be a clinically important predictor of recurrence of breast cancer. [provided by RefSeq, Oct 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.2293979).
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HPR | NM_020995.4 | c.476T>C | p.Ile159Thr | missense_variant | 5/5 | ENST00000540303.7 | NP_066275.3 | |
HPR | NM_001384360.1 | c.116T>C | p.Ile39Thr | missense_variant | 6/6 | NP_001371289.1 | ||
HPR | XM_024450251.2 | c.494T>C | p.Ile165Thr | missense_variant | 5/5 | XP_024306019.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HPR | ENST00000540303.7 | c.476T>C | p.Ile159Thr | missense_variant | 5/5 | 1 | NM_020995.4 | ENSP00000441828.2 | ||
TXNL4B | ENST00000562153.5 | c.284+12477A>G | intron_variant | 4 | ENSP00000454635.2 |
Frequencies
GnomAD3 genomes AF: 0.000552 AC: 84AN: 152200Hom.: 1 Cov.: 32
GnomAD3 genomes
AF:
AC:
84
AN:
152200
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000501 AC: 125AN: 249272Hom.: 2 AF XY: 0.000555 AC XY: 75AN XY: 135212
GnomAD3 exomes
AF:
AC:
125
AN:
249272
Hom.:
AF XY:
AC XY:
75
AN XY:
135212
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000844 AC: 1234AN: 1461812Hom.: 2 Cov.: 32 AF XY: 0.000798 AC XY: 580AN XY: 727204
GnomAD4 exome
AF:
AC:
1234
AN:
1461812
Hom.:
Cov.:
32
AF XY:
AC XY:
580
AN XY:
727204
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000551 AC: 84AN: 152318Hom.: 1 Cov.: 32 AF XY: 0.000604 AC XY: 45AN XY: 74482
GnomAD4 genome
AF:
AC:
84
AN:
152318
Hom.:
Cov.:
32
AF XY:
AC XY:
45
AN XY:
74482
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
5
ExAC
AF:
AC:
58
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 13, 2021 | The c.476T>C (p.I159T) alteration is located in exon 5 (coding exon 5) of the HPR gene. This alteration results from a T to C substitution at nucleotide position 476, causing the isoleucine (I) at amino acid position 159 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Benign
DEOGEN2
Benign
T;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D
M_CAP
Benign
D
MetaRNN
Benign
T;T
MetaSVM
Uncertain
D
MutationAssessor
Benign
L;.
PrimateAI
Uncertain
T
PROVEAN
Benign
N;.
REVEL
Uncertain
Sift
Benign
T;.
Sift4G
Uncertain
T;T
Polyphen
D;.
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at